Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2010 Nov 1.

Published in final edited form as: Wound Repair Regen. 2008 May–Jun;16(3):337–345. doi: 10.1111/j.1524-475X.2008.00388.x

Table 4.

Measures of plasma fatty acid for active and placebo group (Mean±SD)

	Baseline		Week 4		Change

Fatty acids (µM/L)	AC (n=16)	PL (n=14)	AC (n=16)	PL (n=14)	AC (n=16)	PL (n=14)
EPA	20.9±14.9	22.0±29.7	125.2±53.1^a,^b	15.1±8.6^b	99.9±57.8^a,^b	−6.9±30.0^b
DHA	110.1±38.4	102.2±41.2	179.4±42.2^a,^b	83.8±17.9^b	67.3±43.9^a,^b	−18.4±35.5^b
AA	668.7±144.1	644.9±84.4	576.8±121.1^a,^b	651.0±102.2^b	−77.8±105.5^a,^b	6.1±70.4^b
Total
ω-6	2490.6±482.1	2599.6±357.0	2218.7±403.1^a,^b	2589.8±349.9^b	−259.1±290.5^a,^b	−9.8±255.2^b
ω-3	182.2±57.3	187.7±85.0	371.8±94.7^a,^b	158.3±31.2^b	181.3±107.7^a,^b	−29.3±83.9^b
Ratios
AA/EPA	43.8±24.3	49.0±21.8	5.5±2.7^a,^b	57.2±32.0^b	−38.1±25.7^a,^b	8.3±22.9^b
ω-6/ω-3	14.4±3.2	15.2±4.0	6.3±1.6^a,^b	16.8±3.5^b	−8.0±3.7^a,^b	1.6±2.6^b

^a

Significantly different from baseline–within group (p < .05).

^b

Significantly different between groups @ week 4 (p < .05).

AC, active; PL, placebo; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid.